The hospital does clinical research, and the question arises as to how to test treatment options on Alzheimer’s patients who are so confused they cannot consent to be in a drug trial. What should the policy be? See the Alzheimer’s association website as a starting point for your research. Be sure to discuss IRB. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34755…